Detalhe da pesquisa
1.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
N Engl J Med
; 387(20): 1855-1864, 2022 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36342163
2.
Prediction of Venous Thromboembolism in Diverse Populations Using Machine Learning and Structured Electronic Health Records.
Arterioscler Thromb Vasc Biol
; 44(2): 491-504, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38095106
3.
Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19.
Arterioscler Thromb Vasc Biol
; 44(5): 1124-1134, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38511328
4.
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts.
Lancet
; 401(10372): 215-225, 2023 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36563696
5.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34351721
6.
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials.
Cardiovasc Drugs Ther
; 2024 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38446275
7.
Evinacumab in Patients with Refractory Hypercholesterolemia.
N Engl J Med
; 383(24): 2307-2319, 2020 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33196153
8.
Evinacumab for Homozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(8): 711-720, 2020 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32813947
9.
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
Diabetes Obes Metab
; 25(6): 1750-1757, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36843558
10.
Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.
Cardiovasc Drugs Ther
; 37(2): 307-313, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34792686
11.
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
Cardiovasc Drugs Ther
; 2023 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37052867
12.
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
Cardiovasc Drugs Ther
; 37(1): 107-116, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34599698
13.
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
Eur Heart J
; 43(7): e17-e25, 2022 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31270529
14.
LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials.
J Lipid Res
; 63(1): 100148, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34774485
15.
Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a).
Cardiovasc Drugs Ther
; 2022 Nov 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36435949
16.
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19.
Cardiovasc Drugs Ther
; 36(6): 1165-1173, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34524566
17.
Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV.
Cardiovasc Drugs Ther
; 36(1): 173-186, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32979175
18.
Glycocalyx Disruption Triggers Human Monocyte Activation in Acute Heart Failure Syndromes.
Cardiovasc Drugs Ther
; 2022 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36260206
19.
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
Cardiovasc Drugs Ther
; 36(3): 475-481, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33661432
20.
Existing and emerging therapies for the treatment of familial hypercholesterolemia.
J Lipid Res
; 62: 100060, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33716107